EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study

Paula Nistor, Ionica Iancu, Vlad Iorgoni, Alexandru Gligor, Alexandra Blaga, Janos Degi, Livia Stângă, Tiana Suici, Viorel Herman

Pathogens · 2026-11-06 · 15 (11) · 1164

DOI: 10.3390/pathogens15111164 ↗
AbstractBibliografische Angaben

Abstract

Background: Chronic progressive lymphedema (CPL) in draft horses is frequently complicated by secondary cutaneous infection, and Pseudomonas aeruginosa may be difficult to eliminate. This study evaluated topical 2% acetic acid as an adjunct to a standardized local treatment protocol. Methods: Records of 35 hospitalized horses with CPL in which P. aeruginosa was the sole pretreatment isolate were reviewed retrospectively. Seven historical controls received clipping, chlorhexidine cleansing, drying, and polyhexanide irrigation; 28 horses received the same protocol plus 2% acetic acid twice daily. No horse received systemic antimicrobials. Follow-up cultures were collected 24 h after clinical resolution. Results: Median treatment duration was 12 days (IQR 11–14) in controls and 8 days (IQR 7–9) with acetic acid (p < 0.001). P. aeruginosa clearance was achieved in 1/7 (14.3%) and 27/28 (96.4%) horses, respectively (p < 0.001). Subsequent clinical reappearance of P. aeruginosa-associated disease occurred in 6/7 (85.7%) and 3/28 (10.7%) horses (p < 0.001); most control events reflected persistence rather than recurrence after clearance. No local adverse reactions were recorded. Conclusions: Adding topical 2% acetic acid was associated with higher P. aeruginosa clearance, shorter treatment, and fewer subsequent clinical reappearances. Prospective randomized studies are needed to confirm these findings.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →